Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
Iain Murray, Sarah Chittenden, Ana M. Denis-Bacelar, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 11, pp. 1832-1844
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed
Shuncong Wang, Yewei Liu, Yuanbo Feng, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1782-1782
Open Access | Times Cited: 89
Targeted Alpha Therapy: Current Clinical Applications
Francisco Liberal, Joe M. O’Sullivan, Stephen J. McMahon, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 35, Iss. 6, pp. 404-417
Open Access | Times Cited: 74
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre
Ken Herrmann, Luca Giovanella, Andrea Santos, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2300-2309
Open Access | Times Cited: 44
Radionuclide Therapy of Metastatic Prostate Cancer
Clemens Kratochwil, Uwe Haberkorn, Frederik L. Giesel
Seminars in Nuclear Medicine (2019) Vol. 49, Iss. 4, pp. 313-325
Closed Access | Times Cited: 66
Molecular Imaging of Bone Metastases and Their Response to Therapy
Gary Cook, Vicky Goh
Journal of Nuclear Medicine (2020) Vol. 61, Iss. 6, pp. 799-806
Open Access | Times Cited: 58
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach
Luca Filippi, Luca Urso, Francesco Bianconi, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 3, pp. 243-255
Closed Access | Times Cited: 17
Imaging and dosimetry for radium-223: the potential for personalized treatment
Glenn Flux
British Journal of Radiology (2017) Vol. 90, Iss. 1077
Open Access | Times Cited: 60
Advances in targeted alpha therapy for prostate cancer
Giuseppe De Vincentis, W.R. Gerritsen, Jürgen E. Gschwend, et al.
Annals of Oncology (2019) Vol. 30, Iss. 11, pp. 1728-1739
Open Access | Times Cited: 53
Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response
Javian Malcolm, Nadia Falzone, B. Q. Lee, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 268-268
Open Access | Times Cited: 44
Why bother with alpha particles?
Anna King, Frank I. Lin, Freddy E. Escorcia
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 1, pp. 7-17
Closed Access | Times Cited: 32
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
Neeta Pandit‐Taskar, Amir Iravani, Dan Lee, et al.
Journal of Nuclear Medicine (2021) Vol. 62, Iss. Supplement 3, pp. 60S-72S
Open Access | Times Cited: 28
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose–response and threshold absorbed doses
Jean‐Pierre Pouget, Pablo Mínguez Gabiña, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 4
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes
Nadia Benabdallah, William Scheve, Nicholas Dunn, et al.
Theranostics (2021) Vol. 11, Iss. 20, pp. 9721-9737
Open Access | Times Cited: 24
A Primer on Radiopharmaceutical Therapy
Kilian Salerno, Soumyajit Roy, Cathy Ribaudo, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 115, Iss. 1, pp. 48-59
Closed Access | Times Cited: 18
A Projection-Domain Low-Count Quantitative SPECT Method for ɑ-Particle-Emitting Radiopharmaceutical Therapy
Zekun Li, Nadia Benabdallah, Diane S. Abou, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences (2022) Vol. 7, Iss. 1, pp. 62-74
Open Access | Times Cited: 16
Calix[4]arene containing thiourea and coumarin functionality as highly selective fluorescent and colorimetric chemosensor for fluoride ion
Zhengyi Li, Hong-Kui Su, Hong-Xiao Tong, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2018) Vol. 200, pp. 307-312
Closed Access | Times Cited: 32
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)
M.L. Belli, Anna Sarnelli, Emilio Mezzenga, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27
223Ra-dichloride therapy of bone metastasis: optimization of SPECT images for quantification
Nadia Benabdallah, Michela Bernardini, Marta Bianciardi, et al.
EJNMMI Research (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Optimization of a Bayesian penalized likelihood algorithm (Q.Clear) for 18F-NaF bone PET/CT images acquired over shorter durations using a custom-designed phantom
Tokiya Yoshii, Kenta Miwa, Masashi Yamaguchi, et al.
EJNMMI Physics (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Systemic Radiotherapy of Bone Metastases With Radionuclides
Iain Murray, Yong Du
Clinical Oncology (2021) Vol. 33, Iss. 2, pp. 98-105
Open Access | Times Cited: 22
Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer
Vera Höllriegl, Nina Petoussi-Henss, Kerstin Hürkamp, et al.
EJNMMI Physics (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Quantitative Dual-Isotope Planar Imaging of Thorium-227 and Radium-223 Using Defined Energy Windows
Iain Murray, Bruno Rojas, Jonathan Gear, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 35, Iss. 7, pp. 530-539
Open Access | Times Cited: 19
ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner–Collimator Configurations for223Ra-Based Radiopharmaceutical Therapies
Zekun Li, Nadia Benabdallah, Jingqin Luo, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 5, pp. 810-817
Open Access | Times Cited: 2
Bone Metastases
Gary Cook, Matthew Thorpe
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 202-209
Closed Access | Times Cited: 2
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients
Arthur Letellier, Alison Johnson, N. How Kit, et al.
Molecular Imaging and Biology (2017) Vol. 20, Iss. 3, pp. 482-491
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top